Compared with non-GLP-1RA anti-diabetes medications, semaglutide was associated with a significantly lower risk of incident CUD, though the association attenuated over time
The three ingredients work on different pathways: CLA on cellular body composition processes, L-Carnitine on fatty acid mobilisation, and green tea catechins on metabolic rate
While Tirzepatide is currently setting the bar when it comes to weight loss, Retatrutide is testing how high it can go
GLP-1 prices by up to 70% through agreements like the TrumpRx platform, bringing the cost of Ozempic down to about $350 per month
Diet-induced lipid loading into the liver causes a significant increase in the expression of ABC G5/G8 in the bile canaliculi [116]
Celebrated for their weight loss and health benefits, these medications also raise concerns about access, cost, safety and ethics